PB2452

· SFJ Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PB2452, covering 2024-05-01 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers [Phase 1]